Análisis de la acción Aimei Health Technology Co Ltd (AFJK)

Análisis de IA of Aimei Health Technology Co Ltd (AFJK)

Mantener

Aimei Health Technology Co Ltd (AFJK) is currently not a strong buy. The stock is trading at $12.20, significantly down 83.92% year-to-date, indicating severe volatility and potential instability. The RSI is at 50.187, suggesting it is neither overbought nor oversold, but the forward P/E ratio is 0, indicating a lack of earnings expectations. The company has recently faced negative news, including a failure to file its quarterly report on time and the termination of a merger agreement, which has likely shaken investor confidence. The main risk is the company's recent net income drop to -83,144 USD in Q2 2026, which raises concerns about its financial health. Overall, while there may be potential for recovery, the current situation warrants a cautious approach and a hold position for now.

Métricas de valoración

El PER previsto actual de Aimei Health Technology Co Ltd (AFJK) es 0.00, frente a su media de 5 años de 0.00.

PER previsto

Muy infravalorado

Media 5A P/E

0.00

P/E actual

0.00

Sobrevalorada

0.00

Infravalorada

0.00

EV/EBITDA previsto

Muy infravalorado

Media 5A EV/EBITDA

0.00

EV/EBITDA actual

0.00

Sobrevalorada

0.00

Infravalorada

0.00

Precio/ventas previsto

Valor razonable

Media 5A P/S

0.11

P/S actual

0.00

Sobrevalorada

1.24

Infravalorada

-1.01

Escenarios de precio de Alphio AI para AFJK

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%AFJK

$14.53

Precio del escenario

B

Base

Base · 50%AFJK

$12.44

Precio del escenario

B

Bajista

Bajista · 25%AFJK

$10.38

Precio del escenario

Ballenas con AFJK en cartera

W

W. R. Berkley Corporation

+ Con en carteraAFJK

+4.37%

Rentabilidad a 3 meses

Preguntas frecuentes sobre AFJK, respondidas por Alphio AI

Aimei Health Technology Co., Ltd. is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company do not have any specific business combination under consideration and has not nor has anyone on behalf, directly or indirectly, contacted any prospective target business. It has not generated any revenues. It operates in the Financials sector.

Aimei Health Technology Co Ltd (AFJK) is currently not a strong buy. The stock is trading at $12.20, significantly down 83.92% year-to-date, indicating severe volatility and potential instability. The RSI is at 50.187, suggesting it is neither overbought nor oversold, but the forward P/E ratio is 0, indicating a lack of earnings expectations. The company has recently faced negative news, including a failure to file its quarterly report on time and the termination of a merger agreement, which has likely shaken investor confidence. The main risk is the company's recent net income drop to -83,144 USD in Q2 2026, which raises concerns about its financial health. Overall, while there may be potential for recovery, the current situation warrants a cautious approach and a hold position for now.